TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH HEMATOPOIETIC GROWTH-FACTORS

被引：33
作者：
GANSER, A
HOELZER, D
机构：
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1992年 / 6卷 / 03期
关键词：
D O I：
10.1016/S0889-8588(18)30333-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：633 / 653
页数：21
相关论文
共 125 条
[1]  
Andreeff M, 1990, Haematol Blood Transfus, V33, P747
[2]  
ANTIN JH, 1990, EXP HEMATOL, V18, P266
[3]  
ANTIN JH, 1988, BLOOD, V72, P705
[4]   BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH MYELODYSPLASIA - PRETREATMENT VARIABLES AND OUTCOME [J].
APPELBAUM, FR ;
BARRALL, J ;
STORB, R ;
FISHER, LD ;
SCHOCH, G ;
RAMBERG, RE ;
SHULMAN, H ;
ANASETTI, C ;
BEARMAN, SI ;
BEATTY, P ;
BENSINGER, WI ;
BUCKNER, CD ;
CLIFT, RA ;
HANSEN, JA ;
MARTIN, P ;
PETERSEN, FB ;
SANDERS, JE ;
SINGER, J ;
STEWART, P ;
SULLIVAN, KM ;
WITHERSPOON, RP ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (08) :590-597
[5]   INDUCIBILITY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION AND ITS CLINICAL RELEVANCE [J].
ARCHIMBAUD, E ;
BAILLY, M ;
DORE, JF .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) :328-334
[6]  
ASANO Y, 1988, BLOOD, V72, P1682
[7]  
AUL C, 1989, CANCER, V64, P1812, DOI 10.1002/1097-0142(19891101)64:9<1812::AID-CNCR2820640909>3.0.CO
[8]  
2-I
[9]   ENRICHMENT OF HEMATOPOIETIC PROGENITOR CELLS FROM THE MARROW OF PATIENTS WITH MYELODYSPLASIA [J].
BAINES, P ;
MASTERS, GS ;
LUSH, C ;
JACOBS, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (02) :159-164
[10]   PURIFIED COLONY STIMULATING FACTORS (G-CSF AND GM-CSF) INDUCE DIFFERENTIATION IN HUMAN HL60 LEUKEMIC-CELLS WITH SUPPRESSION OF CLONOGENICITY [J].
BEGLEY, CG ;
METCALF, D ;
NICOLA, NA .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (01) :99-105
12345678910